Endoscopic Ultrasound
11
0
1
3
Key Insights
Highlights
Success Rate
50% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 100/100
27.3%
3 terminated out of 11 trials
50.0%
-36.5% vs benchmark
0%
0 trials in Phase 3/4
33%
1 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (11)
EUS-guided Intra-tumour Injection of OncoSil for Locally Advanced Pancreatic Carcinoma.
High Flow Nasal Cannula Compared to Standard Oxygen for Endoscopic Ultrasound
A Physiologic Analysis of Endoscopic Sleeve Gastroplasty (ESG)
Ex-vivo Ultrasound Guided Radiofrequency Ablation on Pancreatic Solid Lesions
Digital Confocal Microscopy for Real-time Diagnosis of Pancreatic Solid Lesion
Primary Prevention of Gastric Varices Bleed
Effectiveness of an Ai-based Endoscopic Ultrasound Navigation System in the Training of Endoscopic Ultrasonics
Wet-suction Versus Slow-pull for EUS-FNB of Solid Lesions
Comparison of Oxygenation Between Nasal PAP vs Nasal During Propofol-based Sedation for EUS
EUS-FNI for Nonfunctional Pancreatic Neuroendocrine Tumors
Non-hypovascular Solid Pancreatic Lesions: Role of EUS